The contribution of a proliferation-inducing ligand (APRIL) and other TNF superfamily members in pathogenesis and progression of IgA nephropathy
Advances in our understanding of the pathogenesis of immunoglobulin A nephropathy
(IgAN) have led to the identification of novel therapeutic targets and potential disease …
(IgAN) have led to the identification of novel therapeutic targets and potential disease …
Immunosuppressive therapy for IgA nephropathy in children
Background IgA nephropathy (IgAN) is the most common cause of primary
glomerulonephritis. It is a heterogeneous disease with different presentations and high …
glomerulonephritis. It is a heterogeneous disease with different presentations and high …
MicroRNAs as a therapeutic target in IgA nephropathy in Indian population
A Tripathy, P Yedla, RV Vishnubhotla… - Biomedical …, 2023 - spandidos-publications.com
Immunoglobulin A nephropathy (IgAN) is the most frequent glomerular disease with rapid
development to end stage renal disease, requiring renal replacement therapy. Genome …
development to end stage renal disease, requiring renal replacement therapy. Genome …
[HTML][HTML] Clinicopathological Characteristics of Adult IgA Nephropathy in the United States
DJ Caster, CW Abner, PD Walker, K Wang… - Kidney International …, 2023 - Elsevier
Introduction IgA nephropathy (IgAN) is a progressive autoimmune kidney disease and a
leading cause of glomerular disease that can result in kidney failure (KF). The median age at …
leading cause of glomerular disease that can result in kidney failure (KF). The median age at …
[HTML][HTML] IgA Nephropathy: A Tale of 3 Continents
SCW Tang - Glomerular Diseases, 2022 - karger.com
Fifty-four years after its original description in 1968 by French pathologists Berger and
Hinglais [1], there is still no approved and effective therapy for IgA nephropathy (IgAN) as of …
Hinglais [1], there is still no approved and effective therapy for IgA nephropathy (IgAN) as of …
Advances in IgA nephropathy management, from pathological insights to personalized treatment.
M Shavakhi, AW Baqir - Journal of Nephropathology, 2023 - search.ebscohost.com
IgA nephropathy is a common glomerulonephritis with variable clinical outcomes. The
optimal treatment for this condition remains uncertain, and corticosteroid therapy is reserved …
optimal treatment for this condition remains uncertain, and corticosteroid therapy is reserved …
[HTML][HTML] Therapeutic Categories
AS Bomback - expertperspectives.com
Researchers and clinicians seek to improve upon the existing approach to immunoglobulin
A nephropathy (IgAN). As the understanding of the pathogenesis of IgAN grows, many new …
A nephropathy (IgAN). As the understanding of the pathogenesis of IgAN grows, many new …